Back to VRTX
Creative Planning VRTX Position History
Vertex Pharmaceuticals Incorporated • Healthcare
Quarters held
16
Latest value
$857K
Q3 2026
Peak value
$71.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $36.7M |
| Q3 2025 | $478K |
| Q4 2025 | $44.9M |
| Q4 2025 | $571K |
| Q4 2025 | $643K |
| Q1 2026 | $676K |
| Q1 2026 | $48.2M |
| Q1 2026 | $379K |
| Q2 2026 | $729K |
| Q2 2026 | $62.7M |
| Q2 2026 | $35K |
| Q2 2026 | $679K |
| Q3 2026 | $850K |
| Q3 2026 | $71.7M |
| Q3 2026 | $7K |
| Q3 2026 | $857K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $857K | 72.8K | — | — |
| Q3 2026 | $7K | 608 | — | — |
| Q3 2026 | $71.7M | 137.1K | — | — |
| Q3 2026 | $850K | 1.6K | — | — |
| Q2 2026 | $679K | 59.1K | — | — |
| Q2 2026 | $35K | 3.1K | — | — |
| Q2 2026 | $62.7M | 126.2K | — | — |
| Q2 2026 | $729K | 1.5K | — | — |
| Q1 2026 | $379K | 31.9K | — | — |
| Q1 2026 | $48.2M | 108.0K | — | — |
| Q1 2026 | $676K | 1.5K | — | — |
| Q4 2025 | $643K | 1.4K | — | — |
| Q4 2025 | $571K | 28.6K | — | — |
| Q4 2025 | $44.9M | 99.1K | — | — |
| Q3 2025 | $478K | 1.2K | — | — |
| Q3 2025 | $36.7M | 93.6K | — | — |
Other funds holding VRTX
$10.8B
$10.1B
$9.8B
$8.5B
$5.9B
$5.9B
$5.7B
$5.5B